FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely oncology, and may be used for treating ovarian cancer. That is ensured by introducing an effective amount of the composition containing a compound of formula 
or its pharmaceutically acceptable salt.
EFFECT: introducing the given compound inhibiting poly-ADP-ribose polymerase lead to disordered cycle of ovarian cancer cells of various lines and their apoptosis that enables effective treatment of cancer of localisation stated above.
13 cl, 3 tbl, 7 ex, 18 dwg
| Title |
Year |
Author |
Number |
| METHODS FOR TREATMENT OF METASTATIC CANCER TYPES, USING AXL TRAP RECEPTORS |
2018 |
- Mcintyre Gail
- Prohaska David
- Tabibiazar Ray
|
RU2785866C2 |
| COMBINED IMMUNOTHERAPEUTIC APPROACH TO CANCER TREATMENT |
2015 |
|
RU2716821C2 |
| METHOD OF TREATING BREAST CANCER WITH COMPOUND OF 4-IODINE-3-NITROBENZAMINE IN COMBINATION WITH ANTICANCER AGENTS |
2008 |
- Sherman Barri M.
- Brehdli Charl'Z
- Ossovskaja Valerija S.
|
RU2480211C2 |
| ORAL COMPOSITION AND METHODS OF IMMUNOTHERAPY |
2015 |
- Burinbajar Aldar
- Dzhiratkhitikal Vichaj
|
RU2719586C2 |
| TARGETING SRC-3 IN IMMUNE CELLS AS IMMUNOMODULATORY THERAPEUTIC AGENT FOR TREATING CANCER |
2021 |
- O'Malley, Bert W.
- Han, Sang Jun
- Lonard, David M.
- Nikolai, Bryan
- Jain, Prashi
- Gilad, Yosef
- Dacso, Clifford
|
RU2828447C1 |
| CONTROL POINT INHIBITOR AND WHOLE-CELL MICROBACTERIA FOR USE IN TREATING ONCOLOGICAL DISEASE |
2014 |
- Ekl Charlz
- Grendzh Dzhon
- Bilyard Kevin
|
RU2719934C2 |
| METHODS OF TREATING CANCER, HAVING HEMIZYGOUS LOSS OF TP53 |
2016 |
|
RU2721953C2 |
| ONCOLYTIC CLOSTRIDIUM GHONII STRAINS, METHODS OF PRODUCTION AND USE |
2013 |
|
RU2667432C2 |
| TREATING CANCER WITH COMBINATION OF RADIATION THERAPY, CERIUM OXIDE NANOPARTICLES AND CHEMOTHERAPEUTIC AGENT |
2015 |
|
RU2704811C2 |
| ABX196 FOR USE IN TREATMENT OF BLADDER CANCER |
2018 |
- Crabe, Sandrine
- Scherrer, Didier
- Ehrlich, Hartmut
- Pouletty, Philippe
|
RU2778812C2 |
